Warner Chilcott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WARNER CHILCOTT, and what generic and branded alternatives to WARNER CHILCOTT drugs are available?
WARNER CHILCOTT has eighty-four approved drugs.
Summary for Warner Chilcott
US Patents: | 0 |
Tradenames: | 42 |
Ingredients: | 39 |
NDAs: | 84 |
PTAB Cases with Warner Chilcott as patent owner: | See PTAB cases with Warner Chilcott as patent owner |
Drugs and US Patents for Warner Chilcott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warner Chilcott | AMITRIL | amitriptyline hydrochloride | TABLET;ORAL | 084957-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Warner Chilcott | SPIRONOLACTONE | spironolactone | TABLET;ORAL | 087952-001 | Nov 18, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Warner Chilcott | KANAMYCIN SULFATE | kanamycin sulfate | INJECTABLE;INJECTION | 063092-001 | Oct 11, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Warner Chilcott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Warner Chilcott | ACTONEL WITH CALCIUM (COPACKAGED) | calcium carbonate; risedronate sodium | TABLET;ORAL | 021823-001 | Aug 12, 2005 | 6,465,443*PED | ⤷ Try a Trial |
Warner Chilcott | ACTONEL WITH CALCIUM (COPACKAGED) | calcium carbonate; risedronate sodium | TABLET;ORAL | 021823-001 | Aug 12, 2005 | 6,015,801*PED | ⤷ Try a Trial |
Warner Chilcott | ACTONEL WITH CALCIUM (COPACKAGED) | calcium carbonate; risedronate sodium | TABLET;ORAL | 021823-001 | Aug 12, 2005 | 6,096,342*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for WARNER CHILCOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2013-08-12 |
➤ Subscribe | Delayed-release Tablets | 80 mg | ➤ Subscribe | 2015-07-01 |
➤ Subscribe | Delayed-release Tablets | 150 mg | ➤ Subscribe | 2008-12-19 |
➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2014-05-19 |
➤ Subscribe | Delayed-release Tablets | 50 mg | ➤ Subscribe | 2015-11-05 |
Similar Applicant Names
Here is a list of applicants with similar names.